Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ajiro, K.
Right arrow Articles by Nishikawa, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ajiro, K.
Right arrow Articles by Nishikawa, Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 271, Number 22, Issue of May 31, 1996 pp. 13197-13201
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Alteration of Cell Cycle-dependent Histone Phosphorylations by Okadaic Acid
INDUCTION OF MITOSIS-SPECIFIC H3 PHOSPHORYLATION AND CHROMATIN CONDENSATION IN MAMMALIAN INTERPHASE CELLS*

(Received for publication, February 21, 1996)

Kozo Ajiro Dagger §, Kinya Yoda , Kazuhiko Utsumi par and Yasuhiro Nishikawa Dagger

From the Dagger  Aichi Cancer Center, Research Institute, Laboratory of Cell Biology and par  Laboratory of Ultrastructure Research, Chikusa-ku and the  Nagoya University, Faculty of Science, Institute of Molecular Biology, Nagoya 464, Japan

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgment
REFERENCES


ABSTRACT

Effects of okadaic acid (OA), a protein phosphatase inhibitor, on chromatin structure and phosphorylation of histones were examined using HeLa and N18 cells. The chromatin condensation in HeLa cells was mild and resemble prometaphase nuclei, while the condensation in N18 cells was extensive and chromatin became a compact body. H2A in HeLa cells was extensively and consistently phosphorylated at the same site throughout the cell cycle, and H3 was demonstrated to be phosphorylated at the mitosis-specific site Ser10. In contrast, H1 phosphorylation was rapidly decreased in most sites within 3 h. The reduction of H1 phosphorylation was accompanied by a quantitative change in the set of H1 phosphopeptides. During the early phase of the OA treatment, H1 phosphorylation was transiently elevated in tandem, whereas H3 phosphorylation reached a maximum somewhat later. The results suggest that mitosis-specific events (cdc2/H1 kinase activation, H1 superphosphorylation, mitosis-specific H3 phosphorylation and chromatin condensation) induced by OA are sequentially associated. The changes appear to reflect a molecular mechanism similar to that operating in normal mitosis.


INTRODUCTION

The control of cell cycle progression is one of the most basic biological systems for which involvement of protein phosphorylation and dephosphorylation has been shown (1, 2). These processes are controlled by protein kinase and phosphatase activities. To understand the mechanisms of chromosome kinetics in mitosis, it is thus crucial to analyze the role of nuclear protein phosphorylations at the initiation of chromatin condensation.

Histones constitute a major component of chromosomes and construct nucleosomes as a basic chromatin element (3). During the cell cycle, three kinds of histones (H1, H2A, and H3)1 are extensively phosphorylated in a histone-specific manner (4). During the late G2 to M phase, the level of H1 phosphorylation reaches a maximum (5, 6, 7, 8, 9) concomitantly with activation of cdc2/H1 kinase (10, 11). Mitosis-specific H3 phosphorylation occurs during M phase (4, 12) or premature chromosome condensation (PCC) (13, 14, 15) at Ser10 (16, 17). The level of H2A phosphorylation has been observed to be constant throughout the cell cycle (4, 9).

Okadaic acid (OA), a specific inhibitor of serine/threonine protein phosphatase (18, 19, 20) and a potential tumor promoter (21), is known to affect mammalian cells and induce mitosis-like processes. The chemical causes rounding of cells, PCC, spindle deconstruction and enhancement of H1 kinase activity (22, 23, 24, 25). The chemical also induces apoptotic cells (26, 27). These phenomena accompany an elevation of overall cellular protein phosphorylations (28, 29). The inhibition of phosphatase activity by OA is associated with increased phosphorylation in which pp1 or pp2A phosphatases are involved. Thus it is possible to investigate the relationship between chromatin condensation and histone phosphorylation during cell proliferation using this agent (30).

In the present investigation, we examined critically the effects of okadaic acid on chromatin condensation and histone phosphorylations in both HeLa and N18 cells and found that OA induces H3 phosphorylation in a mitosis-specific site concomitantly with chromatin condensation in interphase cells.


MATERIALS AND METHODS

Chemicals

OA was provided by Dr. S. Yamada of Nagoya University or purchased from Wako Chemical Co. 6-Dimethylaminopurine (6-DMAP) was purchased from Sigma Stock solution of OA was 1 mM dissolved in dimethyl sulfoxide.

Morphological Observations

HeLa (S-3) or N18 (mouse neuroblastoma) cells were cultured in dishes (9-cm diameter, Falcon) for 2 days. The cells were treated with or without chemicals for 30 min to 2 h. For detailed observation of cell nuclei, cells were plated on coverslips and treated with 0.1-1.0 µM of OA or 0.5-1.0 mM 6-DMAP. After washing two times with phosphate-buffered saline solution, the cells were fixed with Carnoy's solution (methanol:acetic acid, 3:1) for 30 min and stained with 50 µg/ml Hoechst 33258 for 30 min, then washed twice with 90% ethanol and observed by immunofluorescence microscopy (Nikon, Fluophot).

Preparation of 32P-Labeled Histones

Cells were grown in plastic bottles (Coster 3275). For the collection of mitotic cells, logarithmically growing cells were treated with 0.02 µg/ml colcemid for 16 h. Then, loosely attached cells were shaken off and collected. For 32P labeling, cells (approximately 3.5 × 107) grown either in dishes or in suspension culture were resuspended in a phosphate-free medium (8) containing [32P]orthophosphate (40 µCi/ml) with or without chemicals. The cultures were incubated for 3 h or 30 min for pulse labeling at 37 °C. Cells were partially lysed with a solution containing 80 mM NaCl, 20 mM EDTA, and 1% Triton X-100 (pH 7.6). Total histones were extracted twice from chromatin with 0.4 N H2SO4 and the proteins precipitated with 4 volumes of ethanol as described earlier (14).

Acid-Urea Triton X-100 Polyacrylamide Gel Electrophoresis

Samples containing 30 µg of histones were resolved by electrophoresis on 30-cm-long 12% polyacrylamide gel containing 7.5 M urea, 5% acetic acid, and 6 mM Triton X-100 (31). The proteins were run at 120 V for 48 h, and the gels were stained with 0.2% Amido Black and autoradiographed as described previously (14). For the quantitation of protein content, gels were subjected to scanning with a densitometer at 565 nm with a Digital Densitrol (type DMU-33C, Toyo Kogaku Co.). Each protein band in the gel was cut out, and the radioactivity of 32P in the protein was estimated by Cerenkov counting.

Resolution of Phosphopeptides on Cellulose TLC Plates

The procedures used for trypsin digestion and tryptic phosphopeptide mapping of phosphorylated histones have been described previously (32). Phosphorylated histones were resolved by SDS-polyacrylamide gel electrophoresis (33). Individual histones was recovered electrophoretically from gels. After trichloroacetic acid precipitation, proteins were dissolved in 0.05 M sodium bicarbonate and digested with 2% trypsin for 4 h at room temperature. Resolution of the phosphopeptides in the first dimension was by electrophoresis in buffer containing buthanol, acetic acid, water, pyridine, 50:25:900:25 (pH 4.7) at 550 V for 50 min on cellulose TLC plates (Merck, Art 5716) under Isoper (Esso Co.). After the plates were dried, resolution in the second dimension was by ascending chromatography in a solution containing n-butanol, acetic acid, water, pyridine (36.6:11.4:45.3:56.7).

Estimation of H1 Kinase Activity in OA-treated Cells

Cells (4 × 106) were lysed partially with buffer A (10 mM Tris·HCl (pH 7.4), 3 mM MgCl2, 0.5 mM phenylmethylsulfonyl fluoride) containing 0.4% Nonidet P-40. Nuclear pellet was washed once with buffer A without Nonidet P-40. From the nuclear pellet, 0.4 M NaCl soluble proteins were extracted. The extract was centrifuged at 100,000 × g for 30 min. The clarified extract was diluted with beads buffer (34) and was reacted with p13suc1-Sepharose beads (Oncogene Sci, Inc.) for 90 min. The beads were then washed three times with beads buffer A. H1 kinase activity associated with the beads was estimated in a reaction mixture (50 µl) containing 20 mM Tris·HCl (pH 7.5), 1 mM EGTA, 1 mM dithiothreitol, 10 mM MgCl2, 10 µg of HeLa histone H1, 1 µM API (an inhibitor peptide for protein kinase A, Sigma) and 20 µCi of [gamma -32P]ATP (DuPont NEN) with incubation at 30 °C for 15 min. The reaction was stopped by adding 20% trichloroacetic acid on ice. H1 was precipitated and washed once with acetone containing 0.3% HCl and twice with acetone. Then, the proteins were run on SDS gels. Bands were detected by autoradiography of dried gels. For quantitation, labeled bands were excised, and radioactivity was determined by Cerenkov counting.


RESULTS

Chromatin Condensation in OA-treated Cells

To investigate the fine structure of HeLa nuclei treated with OA, cells on coverslips were fixed and stained with DNA binding dyes (Fig. 1). Most of the HeLa cells treated with OA at 0.1-1.0 µM detached from the substratum. In the cells remaining attached, weak chromosome condensation was observed in approximately 80% of nuclei (Fig. 1B), whereas untreated cells had round nuclei with a few mitoses (Fig. 1A). The condensation in HeLa cells was mild and resembled prometaphase nuclei. The extent of condensation varied, suggesting that it depends on the cell stage at the time of administration. Most mitotic nuclei were overcondensed with reduction in size and rounding (Fig. 1B, indicated by an arrowhead). In nuclei pretreated with colcemid for 16 h prior to the addition of OA for 3 h, the number of prometaphase-like or compact nuclei was remarkably increased (data not shown). However, most nuclei of N18 cells were extensively condensed and showed round body with no chromatin fibers (data not shown).


Fig. 1. Chromatin condensation in the presence of OA. HeLa (S-3) cells were cultured at 4.5 × 104/ml on coverslips for 2 days, treated with 1 µM OA for 1 h, washed with saline solution, and then fixed in methanol/acetic acid (3:1) for 30 min. The cells were stained with 50 µg/ml Hoechest 33258 in 90% ethanol, washed twice with 90% ethanol, and dried. Observation was under an immunofluorescence microscope. A, untreated HeLa cells; B, cells treated with 1 µM OA for 1 h.

Analysis of Acid-soluble Nuclear Proteins and Their Phosphorylations in the Presence of OA or DMAP

Since protein phosphorylations are associated with chromosome condensation, histone phosphorylations were examined. HeLa cells were labeled with 32P in the presence of OA or 6-DMAP, and the histones were extracted and analyzed by acid-urea-Triton X-100 gel electrophoresis (Fig. 2). Electrophoretic patterns of the proteins were the same for both control and inhibitor-treated cells, except for additional H2A bands caused by phosphorylation (Fig. 2A, lanes 2 and 3, H2A.1 and H2A.2). H2A and H1 are extensively phosphorylated as observed in most growing cells (Fig. 2A, lane 7). In the OA-treated cells, H2A phosphorylation was remarkably increased (Fig. 2A, lanes 8 and 9) with two subtypes, H2A.1 and H2A.2, incorporating 2 and 2.5 times more of 32P, respectively (Fig. 2A and Table I). It was unexpected that the level of H1 phosphorylation was less than half of that in control cells. H3 was rapidly phosphorylated in all three subtypes (H3.1, H3.2/H3.3) and further increased with an increase in the OA concentration, whereas H2B and H4 remained unphosphorylated. With the N18 cells (Fig. 2B), similar results to OA were obtained, although the phosphorylation rate was lower than HeLa (Fig. 2B, lanes 8 and 9). The data therefore indicated that OA affected histone phosphorylation in a histone-specific manner in the two mammalian interphase cells. Thus, 1) H2A phosphorylation was increased, 2) H1 phosphorylation was extensively decreased, 3) H3 phosphorylation was newly induced in interphase cells, and 4) H2B and H4 remained in an unphosphorylated state as in the control cells, 6-DMAP inhibited both H2A and H1 histone phosphorylations of HeLa cells (Fig. 2A, lanes 11 and 12). The chemical also suppressed the mitotic H3 phosphorylation induced by colcemid (Fig. 2A, lane 10). The HeLa cells with colcemid contained approximately 48% mitotic cells. The decrease of these phosphorylations corresponded to the treatment dose (0.5 mM in lane 11 and 1.0 mM in lane 12) and also to the extent of chromatin decondensation (data not shown). A similar influence with histone dephosphorylation by 6-DMAP was observed (Fig. 2B, lanes 11 and 12) in the N18 cells. Quantitative data for histone phosphorylations in both HeLa and N18 cells in the presence of these two chemicals are summarized in Table I.


Fig. 2. Incorporation of [32P]phosphate into histones in cells in the presence of OA or DMAP. HeLa or N18 cells were labeled with [32P]phosphate (40 µCi/ml) for 3 h, and histones were extracted as described under ``Materials and Methods.'' Forty µg (~3,500 cpm) aliquots of the proteins were run on acid-urea-Triton gel electrophoresis at 120 V for 48 h. The gels were stained with 0.2% Amido Black and then autoradiographed. A, HeLa; B, N18. Lanes 1-3 show the effects of OA on histone phosphorylations, and lanes 4-6, the effects of 6-DMAP. Lane 1, control; lane 2, 0.5 µM OA; lane 3, 1 µM OA; ;lane 4, colcemid only; lane 5, colcemid with 0.5 mg/ml 6-DMAP; lane 6, colcemid with 1 mg/ml 6-DMAP. Lanes 1-6, Amido Black stain and lanes 7-12, 32P autoradiography corresponding to lanes 1-6, respectively.

Table I.

Incorporation of 32P into individual histones (cpm/µg) in the presence of OA or 6-DMAP with colcemid


OA
6-DMAP with colcemid
0 µM 0.5 µM 1.0 µM 0 mM 1.0 mM 2.0 mM

HeLa
H2A.1 149.0 305.3 (2.04) 294.3 (1.98) 125.3 15.4 (0.12) 10.6 (0.08)
H2A.2 137.5 352.0 (2.56) 331.5 (2.41) 125.3
H3.1 6.4 200.3 (31.30) 245.2 (38.30) 38.1
H1 179.5 72.5 (0.40) 94.5 (0.53) 201.4 117.9 (0.59) 67.6 (0.33)
H3.2/.3 4.2 133.2 (31.71) 194.6 (46.30) 23.6
N18
H2A.1 81.5 100.5 (1.23) 104.6 (1.28) 80.0 49.1 (0.61) 26.0 (0.33)
H2A.2 69.3 98.6 (1.31) 90.5 (1.42) 70.4 52.5 (0.75) 26.5 (0.38)
H3.1 10.5 15.7 (1.5) 15.9 (2.8) 12.5
H1 90.6 31.6 (0.35) 19.9 (0.22) 127.1 98.8 (0.78) 37.2 (0.29)
H3.2/.3 8.3 10.6 (1.28) 25.6 (3.08) 11.0

Critical examination of the effective dose of OA for induction of H3 phosphorylation and decreased H1 phosphorylation revealed clear differences between N18 and HeLa cells (Fig. 3). The minimum concentration of OA for induction of H3 phosphorylation in the HeLa case was 0.2 µM (Fig. 3, lane 8), whereas the induction in N18 cells at 0.2 µM was very low (Fig. 3, lane 3). The extent of H3 phosphorylation in N18 cells rapidly increased with low concentrations of OA (0.1-0.5 µM) (Fig. 3, lanes 2-4), to a greater extent than with colcemid (data not shown). H3 phosphorylation reached maximum levels at 0.5 µM in HeLa cells (Fig. 3, lane 9), against 1 µM in N18 cells (Fig. 3, lane 10). In contrast, H1 phosphorylation decreased with an increasing dose of OA in both cell types.


Fig. 3. Incorporation of [32P]Phosphate into H1 and H3 histones in cells treated with various concentrations of OA. 32P-Labeled histone preparation and analysis were conducted as described in the legend to Fig. 3. Histones (30 µg) were loaded on acid-urea-Triton gels and autoradiographed after electrophoresis. The figure shows only the H1 and H3 regions. Numbers 1-6 indicate HeLa histones for 0, 0.1, 0.2, 0.5, 1.0, and 1.5 µM of OA, respectively, and numbers 7-11, those from N18 cells treated with 0, 0.1, 0.2, 0.5, and 1.0 µM of OA, respectively.

Comparison of Histone Phosphopeptides between OA-treated Cells and M Cells

To analyze whether the changes of histone phosphorylations by OA reflect any alteration in the number of phosphorylation sites, [32P]phosphopeptide maps of the three kinds of histones were prepared and compared with those of control cells (Fig. 4). The phosphopeptide of H2A in the OA-treated cells was single (Fig. 4b) and migrated to the same position as with H2A in untreated cells (Fig. 4a). The H2A spot in OA-treated cells was more extensively labeled than that in the control H2A. The positions of individual H1 phosphopeptides with OA (Fig. 4d) were also similar to those in untreated cells (Fig. 4c), but the intensity of the individual phosphopeptide differed considerably. The 32P radioactivity in most spots was reduced and one spot demonstrated intensification (Fig. 4d, indicated by an arrow). The two major H3 phosphopeptides with OA (Fig. 4f) were the same as the two mitotic H3 phosphopeptides (3-1 and 3-2 in Fig. 4e). The amino acid sequences of the phosphopeptides, 3-1 and 3-2 were shown previously to contain the same residue Ser(P)10; the peptide 3-2 is a product of incomplete proteolysis (17). The results indicate that OA does not induce an extra phosphorylation site in both H2A and H1, but does induce H3 phosphorylation in interphase cells exactly at the same site as in mitotic cells and some minor sites.


Fig. 4. Comparison of histone phosphopeptides in OA treated cells and mitotic cells. HeLa cells were treated with either OA (1 µM) for 3 h or colcemid (0.04%) for 16 h. For the final 3 h, cells were labeled with 32P in the presence of the chemical. H1 was extracted with 5% perchloric acid directly from nuclear pellet. H2A and H3 were obtained from total histones separated on SDS-polyacrylamide gels and electrophoretical elution. Fifty µg of H1 or 15 µg of H2A or H3 was digested with 2% trypsin. The minimum counts of radioactivity loaded on TLC plates were approximately 2,500 cpm for H1 and 1,500 cpm for H2A and H3. Resolution of the phosphopeptides on the TLC plates in the first dimension was carried out by electrophoresis, then by chromatography in the second dimension as described under ``Materials and Methods.'' a, H2A in untreated cells; b, H2A in OA-treated; c, H1 in untreated; d, H1 in OA-treated; e, H3 in mitotic cells; f, H3 in OA-treated. The arrow in d indicates a spot with increased relative intensity of 32P. 3-1 and 3-2 in e were identified as peptides containing Ser10 residue in an earlier study (17). Small black dots indicate the origin of the phosphopeptides.

Relationship between H1 Kinase Activity and H1 and H3 Phosphorylations in HeLa Cells in the Presence of OA

Since OA-induced chromatin condensation in interphase cells, H1 superphosphorylation and mitosis-specific H3 phosphorylation were investigated simultaneously (Fig. 5). The H1 and H3 phosphorylations in OA-treated cells were examined by pulse labeling with 32P (Fig. 5a). The H1 kinase activity in the 0.4 M NaCl-soluble nuclear fraction was examined in vitro using HeLa histone H1 as a substrate (Fig. 5a). At the same time, H1 and H3 phosphorylations in aliquots of OA-treated cells were examined by pulse labeling with 32P (Fig. 5b). During the first 30 min after the OA treatment, the incorporation of 32P into H1 did not essentially differ from that of untreated cells (Fig. 5, a and b), and H3 phosphorylation was negligible. H1 phosphorylation was elevated and peaked after 1 h, and H3 phosphorylation reached a maximum level at around 1.5 h. Thereafter, H1 phosphorylation returned to the normal level by 2 h, whereas H3 phosphorylation was maintained at a relatively high level. The data indicate that the kinetics of H3 phosphorylation differed from that of H1 phosphorylation. Quantitative data on H1 kinase activity, H1 phosphorylation, and H3 phosphorylation are shown in Fig. 6.


Fig. 5. Time course of changes in cdc2/H1 kinase activity and H1 and H3 phosphorylations in the presence of OA. 32P-Labeled histones were prepared from OA-treated HeLa cells, and experiments were conducted in parallel with analysis of H1 kinase activity. After OA treatment, aliquots of cells were harvested at 30 min and 1, 2, and 3 h. The cells were lysed, 0.4 M NaCl soluble nuclear proteins were prepared, and H1 kinase activity was examined as described under ``Materials and Methods.'' Remaining cells were pulse-labeled for a 30-min interval with 32P, and histones were prepared. The 32P-labeled histones were run on acid-urea-triton gels. a, H1 kinase activity in the nuclear extract; b, the incorporation of 32P into histones H1 and H3.


Fig. 6. Relationship between H1 kinase activity and H1 and H3 Phosphorylations. The three items, H1 kinase activity in the nuclear extract (diamond ) and the incorporation of 32P into histones H1 (open circle ) and H3 (bullet ) in the presence of OA as shown in the Fig. 5, were quantitated (cpm/µg) and depicted together.


DISCUSSION

The present study confirmed that OA causes interphase cells to demonstrate mitosis-like characteristics in terms of both morphological and biochemical parameters. Thus, 1) most OA-treated interphase cells became round in shape with condensed chromosomes, and 2) mitosis-specific histone H3 phosphorylation was induced, although the other cell cycle-dependent histone phosphorylations (H1 and H2A) were also influenced. Our data imply that OA inhibition of phosphatase results in accumulation of phosphorylated H3 proteins, so condensation of chromatin was induced without the completion of DNA synthesis. 6-DMAP, in contrast, decondenses chromatin and concomitantly dephosphorylates H3 even in cells pretreated with colcemid. The chemical is known to inhibit both MPF kinase activity and protein phosphorylations during the maturation of oocytes (35, 36). Therefore, 6-DMAP inactivates both H1 and H3 kinases and thereby dephosphorylates H1 and H3 phosphorylations, which are accumulated in the presence of colcemid, leading to chromatin decondensation. This result is consistent with that of Th'ng et al. (37), who used staurosporine, another protein kinase inhibitor, and found it induced both H1 and H3 dephosphorylations and chromatin decondensation in FM3A cells. This evidence suggests that chromatin condensation must be regulated by a protein kinase/protein phosphatase related mechanism.

OA-induced chromatin condensation of HeLa cells was relatively weak as compared with the case with N18 or other cells (22). Steinmann et al. (38) reported that chromatin in human and mouse cells is hard to condense by OA. The different extent of chromatin condensation among cell types may derive from different rates of H1 kinase induction. We found that induction of H1 kinase by OA was only two times enhanced in HeLa, against 10 times in baby hamster kidney cells (22). This might be due to a lower content of factors supporting H1 kinase activity, like cyclin (38).

It is known that the Ser/Thr-protein phosphatase inhibitor, OA, specifically inactivates both protein phosphatases, pp1 and pp2A. The pp2A is inhibited completely with 1-2 nM OA, whereas pp1 requires 1 µM (18, 20). At the low concentration of OA (2 nM) giving pp2A inhibition, no appreciable effect was observed in terms of H2A and H3 phosphorylations or chromatin structure. Therefore, the data indicate that H2A or H3 dephosphorylations during the cell cycle involve pp1 rather than pp2A.

The mechanism by which OA induces such a burst increase of H3 phosphorylation remains unclear, and the question of whether H3 can be phosphorylated in its natural state or whether the phosphorylation requires some structural change in chromatin still awaits an answer. The H3 phosphorylation itself was probably accelerated by OA inhibition of the relevant phosphatase rather than by H3 kinase activation, since Ser10 in nucleosomes associated with H1 is hardly phosphorylated in vitro (17, 39).

In the presence of OA, the H1 phosphorylation level decreased after 2-3 h in the present case. Paulson et al. (40) similarly found that mitotic H1 phosphorylation of HeLa cells was inhibited by OA using retardation of phosphorylated proteins in gel electrophoresis. The present data indicate that 1) dephosphorylation of H1 occurs not only in M cells but also in interphase cells and 2) the dephosphorylation occurs only in H1 but not in H2A or H3. One possible explanation for this might be that H1 kinase is inactivated by OA with longer treatment as reported by Schonthal and Feramisco (41). The possibility is supported by the evidence that H2A and H3 phosphorylations are not inhibited by protein kinases other than cdc2/H1 kinase. Alternatively, the protein phosphatase responsible for H1 phosphorylation in vivo is neither pp1, pp2A, or the other new protein phosphatase, as discussed by Paulson et al. (40). Although it has been reported that pp2A (42) or pp1 (43) is involved, the phosphatase responsible in mammalian cells has not been determined yet. The remaining phosphorylated H1 demonstrated that the dephosphorylation of a specific peptide was very slow or uneffected by OA. This indicates that the efficiency of dephosphorylation by a protein phosphatase may depend on the primary structure of the phosphorylation site (44).

The present study revealed that H3 phosphorylation associated with OA occurs at the mitosis-specific site (Ser10). H3 phosphorylation is the most closely associated with chromatin condensation among the three phosphorylatable histones during the cell cycle. Extensive H3 phosphorylation has been observed thus far with various kinds of chromatin condensation; 1) normal mitosis from prophase to anaphase (4), 2) PCC in a hybrid cells between S and M phase cells (13), 3) PCC in tsBN2 at the nonpermissive temperature (14, 15), and 4) PCC in the presence of protein phosphatase inhibitor, OA (present study). In most cases, there is an accompanying high level or transient elevation of H1 phosphorylation. It was earlier proposed that a high level of mitotic H1 phosphorylation may facilitate mitotic H3 phosphorylation (17, 39). It is possible that this site of H3 could become exposed by the transient elevation of H1 phosphorylation and thereby become accessible to H3 kinase. Subsequent to this step, phosphorylated H1 may not be directly involved in chromatin condensation until H1 phosphatase removes the phosphate. This notion may explain the recent controversy regarding the role of H1 in chromatin condensation in that it is not essential in the amphibian embryonic system in vitro (45, 46), whereas it is in growing organisms (47). On the other hand, it is known that OA phosphorylated on 80-kDa proteins binding at AT-rich and on nuclear matrix-associated 70-kDa proteins (48). The effect of these phosphorylated non-histone proteins is not rule out for the chromatin condensation.

The H1 kinase activated by OA is known to be Cdc2-type protein kinase associated with cyclin B, which is same as in mitotic cells (22). The present evidence that transient H1 and mitotic H3 phosphorylations occur in the presence of OA indicates that chromatin condensation with OA in interphase cells is induced by a biochemical mechanism similar to that operating in normal mitosis. The causal relationship between chromatin condensation and H3 phosphorylation now requires elucidation, as well as determination of H3 kinase(s) actions.


FOOTNOTES

*   This work was supported in part by The Sagawa Cancer Research Fund, Japan. The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§   To whom corresponding should be addressed: Aichi Cancer Center, Research Institute, Laboratory of Cell Biology, Chikusa-ku, Nagoya 464, Japan. Tel.: 052-762-6111 (ext. 8821); Fax: 052-763-5233.
1   The abbreviations used are: H, histone; OA, okadaic acid; 6-DMAP, 6-dimethylaminopurine; PCC, premature chromosome condensation; pp1/pp2A, protein phosphatase 1 and 2A.

Acknowledgment

We gratefully acknowledge the guidance and constant encouragement of Dr. T. Okazaki.


REFERENCES

  1. Lewin, B. (1990) Cell 61, 743-752 [CrossRef][Medline] [Order article via Infotrieve]
  2. King, R. W., Jackson, P. K., Kirschner, M. W. (1994) Cell 79, 563-571 [CrossRef][Medline] [Order article via Infotrieve]
  3. van Holde, K. E. (1988) Chromatin , Springer -Verlag, New York
  4. Gurley, L. R., D'Anna, J. A., Barham, S. S., Deaven, L. L., Tobey, R. A. (1978) Eur. J. Biochem. 84, 1-15 [Medline] [Order article via Infotrieve]
  5. Bradbury, E. M., Inglis, R. J., Matthews, H. R. (1974) Nature 247, 257-261 [CrossRef][Medline] [Order article via Infotrieve]
  6. Balhorn, R., Chalkley, R., Granner, D. (1972) Biochemistry 11, 1094-1098 [CrossRef][Medline] [Order article via Infotrieve]
  7. Gurley, L. R., Walters, R. A., Tobey, R. A. (1975) J. Biol. Chem. 250, 3936-3944 [Abstract/Free Full Text]
  8. Ajiro, K., Borun, T. W., Cohen, L. H. (1981) Biochemistry 20, 1445-1454 [CrossRef][Medline] [Order article via Infotrieve]
  9. Dolby, T. W., Ajiro, K., Borun, T. W., Gilmour, R. S., Zweidler, A., Cohen, L. H., Miller, P., Nicolini, C. (1979) Biochemistry 18, 1333-1344 [CrossRef][Medline] [Order article via Infotrieve]
  10. Nurse, P. (1990) Nature 344, 503-508 [CrossRef][Medline] [Order article via Infotrieve]
  11. Nigg, E. A. (1990) Adv. Cancer Res. 55, 271-310 [Medline] [Order article via Infotrieve]
  12. Lake, R. S., Salzman, N. P. (1972) Biochemistry 11, 4817-4826 [CrossRef][Medline] [Order article via Infotrieve]
  13. Hanks, S. K., Rodriguez, L. V., Rao, P. N. (1983) Exp. Cell Res. 148, 293-302 [CrossRef][Medline] [Order article via Infotrieve]
  14. Ajiro, K., Nishimoto, T., Takahashi, T. (1983) J. Biol. Chem. 258, 4534-4538 [Abstract/Free Full Text]
  15. Ajiro, K., Nishimoto, T. (1985) J. Biol. Chem. 260, 15379-15381 [Abstract/Free Full Text]
  16. Paulson, J. R., Taylor, S. S. (1982) J. Biol. Chem. 257, 6064-6072 [Abstract/Free Full Text]
  17. Shibata, K., Inagaki, M., Ajiro, K. (1990) Eur. J. Biochem. 192, 87-93 [Medline] [Order article via Infotrieve]
  18. Bialojan, C., Takai, A. (1988) Biochem. J. 256, 283-290 [Medline] [Order article via Infotrieve]
  19. Cohen, P. (1989) Annu. Rev. Biochem. 58, 453-508 [CrossRef][Medline] [Order article via Infotrieve]
  20. Cohen, P., Holmes, C. F. B., Tsukitani, Y. (1990) Trends Biochem. Sci. 15, 98-102 [CrossRef][Medline] [Order article via Infotrieve]
  21. Sugamura, M., Fujiki, H., Suguri, H., Yoshizawa, S., Hirota, M., Nakayasu, M., Ojika, M., Wakamatsu, K., Yamada, K., Sugimura, T. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 1768-1771 [Abstract/Free Full Text]
  22. Yamashita, K., Yasuda, H., Pines, J., Yasumoto, K., Nishitani, H., Ohtsubo, M., Hunter, T., Sugimura, T., Nishimoto, T. (1990) EMBO J. 9, 4331-4338 [Medline] [Order article via Infotrieve]
  23. Glicksman, N. R., Parsons, S. F., Salmon, E. D. (1992) J. Cell Biol. 119, 1271-1276 [Abstract/Free Full Text]
  24. Picard, A., Capony, J. P., Brautigan, D. L., Doree, M. (1989) J. Cell Biol. 109, 3347-3354 [Abstract/Free Full Text]
  25. Rime, H., Ozen, R. (1990) Dev. Biol. 141, 115-122 [CrossRef][Medline] [Order article via Infotrieve]
  26. Boe, R., Gjertsen, B., Vintermyr, O. K., Houge, G., Lanotte, M., Doskeland, S. O. (1991) Exp. Cell Res. 195, 237-246 [CrossRef][Medline] [Order article via Infotrieve]
  27. Kiguchi, K., Glesne, D., Chubb, C. H., Fujiki, H., Huberman, E. (1994) Cell Growth & Differ. 5, 995-1004 [Abstract]
  28. Haystead, T. A. J., Sim, A. T. R., Carling, D., Honnor, R. C., Tsukitani, Y., Cohen, P., Hardie, D. G. (1989) Nature 337, 78-81 [CrossRef][Medline] [Order article via Infotrieve]
  29. Zheng, B., Woo, C. F., Kuo, J. F. (1991) J. Biol. Chem. 266, 10031-10034 [Abstract/Free Full Text]
  30. Schonthal, A. (1992) New Biol. 4, 16-21 [Medline] [Order article via Infotrieve]
  31. Zweidler, A. (1978) Methods Cell Biol. 17, 223-233 [Medline] [Order article via Infotrieve]
  32. Ajiro, K., Borun, T. W., Shulman, S. D., McFadden, G. M., Cohen, L. H. (1981) Biochemistry 20, 1454-1464 [CrossRef][Medline] [Order article via Infotrieve]
  33. Laemmli, U. K. (1970) Nature 227, 680-685 [CrossRef][Medline] [Order article via Infotrieve]
  34. Meijer, L., Azzi, L., Wang, J. Y. J. (1991) EMBO J. 10, 1545-1554 [Medline] [Order article via Infotrieve]
  35. Neant, I., Guerrier, P. (1988) Exp. Cell Res. 176, 68-79 [CrossRef][Medline] [Order article via Infotrieve]
  36. Szollosi, M. S., Kubiak, J. Z., Debey, P., Pennart, H., Szollosi, D. (1993) J. Cell Sci. 104, 861-872 [Abstract]
  37. Th'ng, J. P. H., Guo, X.-W., Swank, R. A., Crissman, H. A., Bradbury, E. M. (1994) J. Biol. Chem. 269, 9568-9573 [Abstract/Free Full Text]
  38. Steinmann, K. E., Belinsky, G. S., Lee, D., Schlegel, R. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 6843-6847 [Abstract/Free Full Text]
  39. Shibata, K., Ajiro, K. (1993) J. Biol. Chem. 268, 18431-18434 [Abstract/Free Full Text]
  40. Paulson, J. R., Ciesielski, W. A., Schram, B. R., Mesner, P. W. (1994) J. Cell Sci. 107, 267-273 [Abstract]
  41. Schonthal, A., Feramisco, J. R. (1993) Oncogene 8, 433-441 [Medline] [Order article via Infotrieve]
  42. Sola, M. M., Langan, T., Cohen, P. (1991) Biochim. Biophys. Acta 1094, 211-216 [Medline] [Order article via Infotrieve]
  43. Kinoshita, N., Yamano, H., Le Bouffant-Sladeczek, F., Kurooka, H., Ohkura, H., Stone, E. M., Takeuchi, M., Toda, T., Yoshida, T., Yanagida, M. (1991) Cold Spring Harbor Symp. Quant. Biol. 56, 621-628 [Abstract/Free Full Text]
  44. Agostinis, P., Goris, J., Pinna, L. A., Marchiori, F., Perich, J. W., Meyer, H. E., Merlevwde, W. (1990) Eur. J. Biochem. 189, 235-241 [Medline] [Order article via Infotrieve]
  45. Dasso, M., Dimitov, S., Wolffe, A. P. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 12477-12481 [Abstract/Free Full Text]
  46. Ohsumi, K., Katagiri, C., Kishimoto, T. (1993) Science 262, 2033-2035 [Abstract/Free Full Text]
  47. Shen, X., Yu, L., Weir, J. W., Gorovsky, M. A. (1995) Cell 82, 47-56 [CrossRef][Medline] [Order article via Infotrieve]
  48. Riebar, M. S., Riebar, M. (1992) Cancer Res. 52, 6397-6399 [Abstract/Free Full Text]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
P. Rodriguez-Collazo, S. H. Leuba, and J. Zlatanova
Robust methods for purification of histones from cultured mammalian cells with the preservation of their native modifications
Nucleic Acids Res., June 1, 2009; 37(11): e81 - e81.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
W.-H. Cheng, D. Muftic, M. Muftuoglu, L. Dawut, C. Morris, T. Helleday, Y. Shiloh, and V. A. Bohr
WRN Is Required for ATM Activation and the S-Phase Checkpoint in Response to Interstrand Cross-Link-Induced DNA Double-Strand Breaks
Mol. Biol. Cell, September 1, 2008; 19(9): 3923 - 3933.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
W. Wang, L. Chen, Y. Ding, J. Jin, and K. Liao
Centrosome separation driven by actin-microfilaments during mitosis is mediated by centrosome-associated tyrosine-phosphorylated cortactin
J. Cell Sci., April 15, 2008; 121(8): 1334 - 1343.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
X. Lin, C.-C. Liu, Q. Gao, X. Zhang, G. Wu, and W.-H. Lee
RINT-1 Serves as a Tumor Suppressor and Maintains Golgi Dynamics and Centrosome Integrity for Cell Survival
Mol. Cell. Biol., July 1, 2007; 27(13): 4905 - 4916.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. I. Harrell, B. M. Iritani, and A. Ruddell
Tumor-Induced Sentinel Lymph Node Lymphangiogenesis and Increased Lymph Flow Precede Melanoma Metastasis
Am. J. Pathol., February 1, 2007; 170(2): 774 - 786.
[Abstract] [Full Text] [PDF]


Home page
GENES CELLSHome page
K. Hara, K. I. Nakayama, and K. Nakayama
Geminin is essential for the development of preimplantation mouse embryos
Genes Cells, November 1, 2006; 11(11): 1281 - 1293.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J.-H. Park, M.-L. Lin, T. Nishidate, Y. Nakamura, and T. Katagiri
PDZ-Binding Kinase/T-LAK Cell-Originated Protein Kinase, a Putative Cancer/Testis Antigen with an Oncogenic Activity in Breast Cancer.
Cancer Res., September 15, 2006; 66(18): 9186 - 9195.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
J. M. Pinkston, D. Garigan, M. Hansen, and C. Kenyon
Mutations that increase the life span of C. elegans inhibit tumor growth.
Science, August 18, 2006; 313(5789): 971 - 975.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
H. Tamada, N. V. Thuan, P. Reed, D. Nelson, N. Katoku-Kikyo, J. Wudel, T. Wakayama, and N. Kikyo
Chromatin Decondensation and Nuclear Reprogramming by Nucleoplasmin
Mol. Cell. Biol., February 15, 2006; 26(4): 1259 - 1271.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
J. Pietsch, J.-M. Delalande, B. Jakaitis, J. D. Stensby, S. Dohle, W. S. Talbot, D. W. Raible, and I. T. Shepherd
lessen encodes a zebrafish trap100 required for enteric nervous system development
Development, February 1, 2006; 133(3): 395 - 406.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
J. I. Morrison, S. Loof, P. He, and A. Simon
Salamander limb regeneration involves the activation of a multipotent skeletal muscle satellite cell population
J. Cell Biol., January 30, 2006; 172(3): 433 - 440.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
S. Y. Lee, S. Voronov, K. Letinic, A. C. Nairn, G. Di Paolo, and P. De Camilli
Regulation of the interaction between PIPKI{gamma} and talin by proline-directed protein kinases
J. Cell Biol., February 28, 2005; 168(5): 789 - 799.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
G. Zachos, M. D. Rainey, and D. A. F. Gillespie
Chk1-Dependent S-M Checkpoint Delay in Vertebrate Cells Is Linked to Maintenance of Viable Replication Structures
Mol. Cell. Biol., January 15, 2005; 25(2): 563 - 574.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
J. de Melo, G. Du, M. Fonseca, L.-A. Gillespie, W. J. Turk, J. L. R. Rubenstein, and D. D. Eisenstat
Dlx1 and Dlx2 function is necessary for terminal differentiation and survival of late-born retinal ganglion cells in the developing mouse retina
Development, January 15, 2005; 132(2): 311 - 322.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Zhang, S.-Q. Kuang, L. Liao, S. Zhou, and J. Xu
Haploid Inactivation of the Amplified-in-Breast Cancer 3 Coactivator Reduces the Inhibitory Effect of Peroxisome Proliferator-Activated Receptor {gamma} and Retinoid X Receptor on Cell Proliferation and Accelerates Polyoma Middle-T Antigen-Induced Mammary Tumorigenesis in Mice
Cancer Res., October 1, 2004; 64(19): 7169 - 7177.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
F. Marlow,, E. M. Gonzalez,,, C. Yin, C. Rojo, and L. Solnica-Krezel,
No tail co-operates with non-canonical Wnt signaling to regulate posterior body morphogenesis in zebrafish
Development, January 1, 2004; 131(1): 203 - 216.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
C. Prigent and S. Dimitrov
Phosphorylation of serine 10 in histone H3, what for?
J. Cell Sci., September 15, 2003; 116(18): 3677 - 3685.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-Q. Kuang, L. Liao, H. Zhang, F. A. Pereira, Y. Yuan, F. J. DeMayo, L. Ko, and J. Xu
Deletion of the Cancer-amplified Coactivator AIB3 Results in Defective Placentation and Embryonic Lethality
J. Biol. Chem., November 15, 2002; 277(47): 45356 - 45360.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
P. J. Simpson, I. Miller, C. Moon, A. L. Hanlon, D. J. Liebl, and G. V. Ronnett
Atrial Natriuretic Peptide Type C Induces a Cell-Cycle Switch from Proliferation to Differentiation in Brain-Derived Neurotrophic Factor- or Nerve Growth Factor-Primed Olfactory Receptor Neurons
J. Neurosci., July 1, 2002; 22(13): 5536 - 5551.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. S. Kim, J. H. Cho, H. W. Park, H. Yoon, M. S. Kim, and S. C. Kim
Endotoxin-Neutralizing Antimicrobial Proteins of the Human Placenta
J. Immunol., March 1, 2002; 168(5): 2356 - 2364.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. Crosio, G. M. Fimia, R. Loury, M. Kimura, Y. Okano, H. Zhou, S. Sen, C. D. Allis, and P. Sassone-Corsi
Mitotic Phosphorylation of Histone H3: Spatio-Temporal Regulation by Mammalian Aurora Kinases
Mol. Cell. Biol., February 1, 2002; 22(3): 874 - 885.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
H. Pendeville, N. Carpino, J.-C. Marine, Y. Takahashi, M. Muller, J. A. Martial, and J. L. Cleveland
The Ornithine Decarboxylase Gene Is Essential for Cell Survival during Early Murine Development
Mol. Cell. Biol., October 1, 2001; 21(19): 6549 - 6558.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
H. Takai, K. Tominaga, N. Motoyama, Y. A. Minamishima, H. Nagahama, T. Tsukiyama, K. Ikeda, K. Nakayama, M. Nakanishi, and K.-i. Nakayama
Aberrant cell cycle checkpoint function and early embryonic death in Chk1-/- mice
Genes & Dev., June 15, 2000; 14(12): 1439 - 1447.
[Abstract] [Full Text]


Home page
JCBHome page
M. Lowe, N. K. Gonatas, and G. Warren
The Mitotic Phosphorylation Cycle of the cis-Golgi Matrix Protein GM130
J. Cell Biol., April 17, 2000; 149(2): 341 - 356.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
P. Adenot, E Campion, E Legouy, C. Allis, S Dimitrov, J Renard, and E. Thompson
Somatic linker histone H1 is present throughout mouse embryogenesis and is not replaced by variant H1 degrees
J. Cell Sci., January 8, 2000; 113(16): 2897 - 2907.
[Abstract] [PDF]


Home page
DevelopmentHome page
T Karashima, A Sugimoto, and M Yamamoto
Caenorhabditis elegans homologue of the human azoospermia factor DAZ is required for oogenesis but not for spermatogenesis
Development, January 3, 2000; 127(5): 1069 - 1079.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
H. Goto, Y. Tomono, K. Ajiro, H. Kosako, M. Fujita, M. Sakurai, K. Okawa, A. Iwamatsu, T. Okigaki, T. Takahashi, et al.
Identification of a Novel Phosphorylation Site on Histone H3 Coupled with Mitotic Chromosome Condensation
J. Biol. Chem., September 3, 1999; 274(36): 25543 - 25549.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
A. Renglin, A.-S. Harmala-Brasken, J. E. Eriksson, and A. Onfelt
Mitotic aberrations induced by carbaryl reflect tyrosine kinase inhibition with coincident up-regulation of serine/threonine protein phosphatase activity: implications for coordination of karyokinesis and cytokinesis
Mutagenesis, May 1, 1999; 14(3): 327 - 333.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. Harzsch, J. Miller, J. Benton, and B. Beltz
From Embryo to Adult: Persistent Neurogenesis and Apoptotic Cell Death Shape the Lobster Deutocerebrum
J. Neurosci., May 1, 1999; 19(9): 3472 - 3485.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
D. M. Sauve, H. J. Anderson, J. M. Ray, W. M. James, and M. Roberge
Phosphorylation-induced Rearrangement of the Histone H3 NH2-terminal Domain during Mitotic Chromosome Condensation
J. Cell Biol., April 19, 1999; 145(2): 225 - 235.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
B Alsina, M Corominas, M. Berry, J Baguna, and F Serras
Disruption of selenoprotein biosynthesis affects cell proliferation in the imaginal discs and brain of Drosophila melanogaster
J. Cell Sci., January 9, 1999; 112(17): 2875 - 2884.
[Abstract] [PDF]


Home page
DevelopmentHome page
L Manning and C. Doe
Prospero distinguishes sibling cell fate without asymmetric localization in the Drosophila adult external sense organ lineage
Development, January 5, 1999; 126(10): 2063 - 2071.
[Abstract] [PDF]


Home page
Mol. Endocrinol.Home page
D. A. DeManno, J. E. Cottom, M. P. Kline, C. A. Peters, E. T. Maizels, and M. Hunzicker-Dunn
Follicle-Stimulating Hormone Promotes Histone H3 Phosphorylation on Serine-10
Mol. Endocrinol., January 1, 1999; 13(1): 91 - 105.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Wei, C. A. Mizzen, R. G. Cook, M. A. Gorovsky, and C. D. Allis
Phosphorylation of histone H3 at serine 10 is correlated with chromosome condensation during mitosis and meiosis in Tetrahymena
PNAS, June 23, 1998; 95(13): 7480 - 7484.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
T. T. Su, F. Sprenger, P. J. DiGregorio, S. D. Campbell, and P. H. O'Farrell
Exit from mitosis in Drosophila syncytial embryos requires proteolysis and cyclin degradation, and is associated with localized dephosphorylation
Genes & Dev., May 15, 1998; 12(10): 1495 - 1503.
[Abstract] [Full Text]


Home page
J. Cell Sci.Home page
A Van Hooser, D. Goodrich, C. Allis, B. Brinkley, and M. Mancini
Histone H3 phosphorylation is required for the initiation, but not maintenance, of mammalian chromosome condensation
J. Cell Sci., January 12, 1998; 111(23): 3497 - 3506.
[Abstract] [PDF]


Home page
J. Cell Sci.Home page
P. Gowdy, H. Anderson, and M Roberge
Entry into mitosis without Cdc2 kinase activation
J. Cell Sci., January 11, 1998; 111(22): 3401 - 3410.
[Abstract] [PDF]


Home page
DevelopmentHome page
L. Kadyk and J Kimble
Genetic regulation of entry into meiosis in Caenorhabditis elegans
Development, January 5, 1998; 125(10): 1803 - 1813.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
L. J. Thompson, M. Bollen, and A. P. Fields
Identification of Protein Phosphatase 1 as a Mitotic Lamin Phosphatase
J. Biol. Chem., November 21, 1997; 272(47): 29693 - 29697.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. E. Murnion, R. R. Adams, D. M. Callister, C. D. Allis, W. C. Earnshaw, and J. R. Swedlow
Chromatin-associated Protein Phosphatase 1 Regulates Aurora-B and Histone H3 Phosphorylation
J. Biol. Chem., July 6, 2001; 276(28): 26656 - 26665.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Zhong, C. Jansen, Q.-B. She, H. Goto, M. Inagaki, A. M. Bode, W.-Y. Ma, and Z. Dong
Ultraviolet B-induced Phosphorylation of Histone H3 at Serine 28 Is Mediated by MSK1
J. Biol. Chem., August 24, 2001; 276(35): 33213 - 33219.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. C. Galasinski, D. F. Louie, K. K. Gloor, K. A. Resing, and N. G. Ahn
Global Regulation of Post-translational Modifications on Core Histones
J. Biol. Chem., January 18, 2002; 277(4): 2579 - 2588.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-P. Zhong, W.-Y. Ma, and Z. Dong
ERKs and p38 Kinases Mediate Ultraviolet B-induced Phosphorylation of Histone H3 at Serine 10
J. Biol. Chem., July 7, 2000; 275(28): 20980 - 20984.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ajiro, K.
Right arrow Articles by Nishikawa, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ajiro, K.
Right arrow Articles by Nishikawa, Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement